Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
174 Results Found
FDA discloses warning letters for dozens of drug companies
The Food and Drug Administration recently disclosed dozens of warning letters sent to drug companies that accuse them of using misleading or deceptive advertising.
Trump directs HHS, FDA to require full safety warnings in drug ads
President Trump Sept. 10 signed a memorandum directing the Department of Health and Human Services and Food and Drug Administration to require drug companies to include full safety warnings on their consumer advertisements.
Indiana hospital CEO named to AHA Board of Trustees
The AHA Sept. 9 announced Eric Fish, M.D., president and CEO of Schneck Medical Center in Seymour, Ind., has been elected to fill a vacancy on its Board of Trustees effective immediately for a term that ends Dec. 31, 2026.
Administration modifies scope of reciprocal tariffs
The White House Sept. 5 issued an executive order modifying the scope of reciprocal tariffs announced in April to establish a framework of trade deals with international partners on certain goods such as critical minerals and pharmaceutical products.
AHA supports bill covering patient costs for naloxone
The AHA Sept. 4 expressed support for the Hospitals As Naloxone Distribution Sites Act (H.R. 5120), legislation that would require Medicare and Medicaid to cover costs when hospitals provide naloxone to patients at risk of an overdose at no cost to patients.
Monarez out as CDC director, Jim O’Neill named acting director
The Department of Health and Human Services announced Aug. 27 in a post on X that Susan Monarez was no longer director of the Centers for Disease Control and Prevention.
Weather threats to drug production facilities examined in study
A JAMA study published Aug. 20 found that nearly 63% of all U.S. drug production facilities from 2019 through 2024 were in counties where a weather disaster declaration was declared.
B. Braun Medical recalls certain IV fluids
B. Braun Medical has voluntarily recalled two lots of Lactated Ringer’s Injection USP 1000 mL and 0.9% Sodium Chloride Injection USP 1000 mL IV fluids due to particles inside the container, according to the Food and Drug Administration.
Administration orders six-month stockpile of ingredients for domestic drug supply
The White House Aug. 13 released an executive order directing the Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response to develop a list of 26 drugs considered critical for national health and security.
FDA recalls filters for potential of serious harm; voluntary notice issued for soaps, cleansers
The Food and Drug Administration has identified a Class I recall of Draeger SafeStar and TwinStar Filters due to a risk of misleading carbon dioxide readings.